View Part 2: http://www.youtube.com/watch?v=sCfWzZQmVSA
As a result of these Congressional Hearings, the MD-CARE Act was passed in December of 2001. The bipartisan MD-CARE Act provides important authority and direction for muscular dystrophy research, including Duchenne. It established a coordinating council, authorized Centers of Excellence for muscular dystrophy at the NIH; and helped to finally create standards of care for Duchenne through the CDC. In 2008, the MD-CARE Act was successfully reauthorized.
Learn more about Parent Project Muscular Dystrophy's advocacy efforts by visiting our website: ParentProjectMD.org.
Link to this comment:
All Comments (0)